253 related articles for article (PubMed ID: 6390167)
1. Ferrochelatase and N-alkylated porphyrins.
Cole SP; Marks GS
Mol Cell Biochem; 1984 Sep; 64(2):127-37. PubMed ID: 6390167
[TBL] [Abstract][Full Text] [Related]
2. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
Marks GS; Allen DT; Johnston CT; Sutherland EP; Nakatsu K; Whitney RA
Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of 3-ethoxycarbonyl-1,4-dihydro-2,4-dimethylpyridine and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity and heme biosynthesis in chick embryo liver cells in culture.
Marks GS; Allen DT; Sutherland EP; McCluskey SA; Whitney RA
Can J Physiol Pharmacol; 1986 Apr; 64(4):483-6. PubMed ID: 3730932
[TBL] [Abstract][Full Text] [Related]
4. Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes.
Cole SP; Massey TE; Marks GS; Racz WJ
Can J Physiol Pharmacol; 1981 Nov; 59(11):1155-8. PubMed ID: 7317839
[TBL] [Abstract][Full Text] [Related]
5. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR
Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522
[TBL] [Abstract][Full Text] [Related]
6. Isolation of an N-alkylprotoporphyrin IX from chick embryo livers following the administration of 3,5-diethoxycarbonyl-1,4-dihydro-4-ethyl-2,6-dimethylpyridine.
McCluskey SA; Sutherland EP; Racz WJ; Marks GS
Can J Physiol Pharmacol; 1987 Jul; 65(7):1500-2. PubMed ID: 3664364
[TBL] [Abstract][Full Text] [Related]
7. Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics.
Kobus SM; Wong SG; Marks GS
Can J Physiol Pharmacol; 2001 Sep; 79(9):814-21. PubMed ID: 11599783
[TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of delta-aminolevulinic acid synthase activity by N-ethylprotoporphyrin IX and 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-isobutylpyridine .
Mackie JE; Marks GS
Biochem Pharmacol; 1989 Jul; 38(13):2169-73. PubMed ID: 2735955
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ferrochelatase by N-methylprotoporphyrin IX is not accompanied by delta-aminolevulinic acid synthetase induction in chick embryo liver cell culture.
Cole SP; Marks GS; Oritz de Montellano PR; Kunze KL
Can J Physiol Pharmacol; 1982 Feb; 60(2):212-5. PubMed ID: 6896292
[TBL] [Abstract][Full Text] [Related]
10. Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryo and rodents.
Marks GS; Powles J; Lyon M; McCluskey S; Sutherland E; Zelt D
Ann N Y Acad Sci; 1987; 514():113-27. PubMed ID: 3126696
[TBL] [Abstract][Full Text] [Related]
11. 2,2-Dialkyl-1,2-dihydroquinolines: cytochrome P-450 catalyzed N-alkylporphyrin formation, ferrochelatase inhibition, and induction of 5-aminolevulinic acid synthase activity.
Lukton D; Mackie JE; Lee JS; Marks GS; Ortiz de Montellano PR
Chem Res Toxicol; 1988; 1(4):208-15. PubMed ID: 2979733
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals.
Brady AM; Lock EA
Arch Toxicol; 1992; 66(3):175-81. PubMed ID: 1497480
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of cytochrome P450 and inhibition of ferrochelatase by analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine with 4-nonyl and 4-dodecyl substituents.
McCluskey SA; Riddick DS; Mackie JE; Kimmett SM; Whitney RA; Marks GS
Can J Physiol Pharmacol; 1992 Aug; 70(8):1069-74. PubMed ID: 1473038
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
[TBL] [Abstract][Full Text] [Related]
15. The 1986 Upjohn award lecture. Interaction of chemicals with hemoproteins: implications for the mechanism of action of porphyrinogenic drugs and nitroglycerin.
Marks GS
Can J Physiol Pharmacol; 1987 Jun; 65(6):1111-9. PubMed ID: 3113708
[TBL] [Abstract][Full Text] [Related]
16. Studies on the inhibition of ferrochelatase by N-alkylated dicarboxylic porphyrins. Steric factors involved and evidence that the inhibition is reversible.
De Matteis F; Gibbs AH; Harvey C
Biochem J; 1985 Mar; 226(2):537-44. PubMed ID: 3838893
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
Cole SP; Zelt DT; Marks GS
Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
[No Abstract] [Full Text] [Related]
18. Effect of decreased ferrochelatase activity on iron and porphyrin content in mitochondria of mice with porphyria induced by griseofulvin.
Tangerås A
Biochim Biophys Acta; 1986 Jun; 882(1):77-84. PubMed ID: 3707999
[TBL] [Abstract][Full Text] [Related]
19. Liver ferrochelatase from normal and hexachlorobenzene porphyric rats. Studies on their properties.
Rios de Molina MC; Taira MC; San Martin de Viale LC
Int J Biochem; 1989; 21(2):219-25. PubMed ID: 2744203
[TBL] [Abstract][Full Text] [Related]
20. Purification and substrate specificity of bovine liver-ferrochelatase.
Taketani S; Tokunaga R
Eur J Biochem; 1982 Oct; 127(3):443-7. PubMed ID: 7173190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
